Did Hedge Funds Make The Right Call On The Meet Group, Inc. (MEET) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Posts Tagged ‘NASDAQ:MEET’
Hedge Funds Have Never Been This Bullish On The Meet Group, Inc. (MEET)
In this article we will check out the progression of hedge fund sentiment towards The Meet Group, Inc. (NASDAQ:MEET) and determine whether it is a good investment right now.
Hedge Funds Dropped The Ball On The Meet Group, Inc. (MEET)
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Hedge Funds Are Dumping The Meet Group, Inc. (MEET)
We can judge whether The Meet Group, Inc. (NASDAQ:MEET) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their...
Here is What Hedge Funds Think About The Meet Group, Inc. (MEET)
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as...
Hedge Fund and Insider Trading News: Carl Icahn, Crispin Odey, ValueAct Capital, La Jolla Pharmaceutical (LJPC), New Mountain Finance Corp. (NMFC), and More
Billionaire activist investor Carl Icahn is building a stake in casino company Caesars Entertainment, sources familiar with the situation said.
Hedge Fund and Insider Trading News: David Einhorn, Marshall Wace LLP, Ra Pharmaceuticals Inc (RARX), PLx Pharma Inc (PLXP), Opko Health Inc. (OPK), and More
David Einhorn closed out 2018 with his biggest annual loss ever for the 22-year-old Greenlight Capital.
13G Filing: Luxor Capital Group and Meet Group Inc. (MEET)
Please follow Luxor Capital Group (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Luxor Capital Group or update its stock holdings...
13D Filing: Harvest Capital Strategies and Meet Group Inc. (MEET)
Please follow Harvest Capital Strategies (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Harvest Capital Strategies or update...
33 Key Stories to Find Out What’s Happening in the Finance World Today
"The S&P 500 and Nasdaq Composite struggled to remain in record territory Tuesday as investors sifted through mostly upbeat earnings reports amid a drop in oil prices and paid...
13D Filing: Harvest Capital Strategies and Meetme Inc. (NASDAQ:MEET)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...
MeetMe Inc (MEET): Bullish Smart Money Positions Have Doubled in Just 2 Quarters
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Social Media Stocks Hedge Funds Like
Indeed, the world of media has been changing at an extremely high pace in recent years and decades.
A Look at Five Stocks Gaining Ground on Wednesday
US stocks are trading in the red on Wednesday as traders await the release of minutes from the Federal Reserve’s July meeting, which might give clues on the rate hike timing...
The 5 Social Networking Stocks That Hedge Funds Are Most Bullish On
Social networking stocks have been in the news constantly this year.
Small Companies, Big Declines: Why These Stocks Tumbled Today
The markets can’t seem to catch a break in 2016; on Wednesday, all major U.S stock indexes continued to decline.
Why Are Investors Excited About These Five Stocks Today?
With all three indices in the red today, shares of Cadiz Inc (NASDAQ:CDZI), Giga-tronics, Incorporated (NASDAQ:GIGA), MeetMe Inc (NASDAQ:MEET), Solaredge Technologies Inc (NASDAQ...
Why MeetMe Inc (MEET), La Jolla Pharmaceutical Co. (LJPC), & Sorrento Therapeutics Inc (SRNE) Surged Last Week
MeetMe Inc (NASDAQ:MEET), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), and Sorrento Therapeutics Inc (NASDAQ:SRNE) experienced a formidable surge on the stock market last week.
